Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitomycin C as adjunctive therapy with glaucoma implant surgery

R Susanna1, M T Nicolela, W Y Takahashi

  • 1Department of Ophthalmology, Albert Einstein Israelite Hospital, São Paulo, Brazil.

Ophthalmic Surgery
|July 1, 1994
PubMed
Summary

Glaucoma implant surgery using a modified Molteno implant and mitomycin C effectively lowered intraocular pressure (IOP) in refractory glaucoma patients. This surgical approach shows promise for managing complex glaucoma cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unraveling Azospirillum's colonization ability through microbiological and molecular evidence.

Journal of applied microbiology·2023
Same author

Impact of seed-applied fungicide and insecticide on Azospirillum brasilense survival and wheat growth-promoting ability.

Letters in applied microbiology·2021
Same author

Rates of glaucomatous visual field change after trabeculectomy.

The British journal of ophthalmology·2016
Same author

Rates of retinal nerve fibre layer thickness change in glaucoma patients and control subjects.

Eye (London, England)·2012
Same author

Micrognathia.

American journal of diseases of children (1911)·2010
Same author

Automated perimetry: a study of the glaucoma hemifield test for the detection of early glaucomatous visual field loss.

Journal of glaucoma·2009

Area of Science:

  • Ophthalmology
  • Surgical Innovation
  • Glaucoma Management

Background:

  • Refractory glaucoma presents significant challenges for intraocular pressure (IOP) control.
  • Standard treatments may be insufficient for severe or complex glaucoma cases.

Purpose of the Study:

  • To evaluate the efficacy and safety of modified Molteno implant surgery combined with mitomycin C in patients with refractory glaucoma.
  • To assess the impact on intraocular pressure and identify potential complications.

Main Methods:

  • A cohort of 21 patients with refractory glaucoma underwent glaucoma surgery.
  • The procedure involved the implantation of a modified Molteno device.
  • Mitomycin C was applied intraoperatively to enhance surgical outcomes.

Related Experiment Videos

Main Results:

  • A significant majority of eyes (76.2%) achieved an IOP of 21 mm Hg or less post-surgery.
  • The mean follow-up period was 9.4 months, with six patients requiring additional IOP-lowering medication.
  • Major complications included early flat anterior chamber (42.9%) and implant-related issues such as plate erosion (9.5%).

Conclusions:

  • Glaucoma implant surgery with adjunctive mitomycin C appears to be a potentially useful treatment for refractory glaucoma.
  • Careful patient selection and monitoring are essential due to the risk of complications.